I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference

News provided by

Apr 05, 2024, 07:00 ET

ROCKVILLE, Md., April 5, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the 23^rd Annual Needham Virtual Healthcare Conference on April 11, 2024.

23^rd Annual Needham Virtual Healthcare Conference

Presentation Time	Thursday, April 11 at 10:15 a.m. EST
Presenters	Raj Kannan, CEO; John Hayslip CMO
Webcast link	Here
Meetings	One-on-one and small group meetings: April 11, 2024
Management Participants	Raj Kannan, CEO Joe Skelton, CFO John Hayslip, CMO Tyler Ehler, Senior Director, Investor Relations

The webcast will also be available under "Event Calendar" on I-Mab's IR website
at http://ir.i-mabbiopharma.com/

For more information, please contact your Needham representative.

About I-Mab

I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and in San Diego, California. For more information, please visit http://www.i-mabbiopharma.com and follow us on LinkedIn and X.

For more information, please contact:
Tyler Ehler
Senior Director, Investor Relations
[email protected]

SOURCE I-Mab Biopharma